Analysis of the Prevalence of Atrial Fibrillation and the Risk Factors in Hypertensive Population

Tao Wang,Shen-sheng Ye,Wei Zhou,Ling-juan Zhu,Xiao Huang,Hui-hui Bao,Xiao-shu Cheng
DOI: https://doi.org/10.1093/ajh/hpad016
2023-01-01
American Journal of Hypertension
Abstract:BackgroundTo investigate the prevalence of atrial fibrillation in the hypertensive population and analyze its related factors to provide relevant scientific basis for the formulation of primary prevention of cardiovascular disease.MethodsFrom March 2018 to August 2018, 14,268 residents were screened for physical examination and hypertension in Wuyuan district, Jiangxi Province, and collected information on demographic characteristics, life behavior patterns, personal disease history, and other information of survey subjects through questionnaire surveys. The central atrial fibrillation was determined by a 12-lead ECG examination and self-reported atrial fibrillation history. Logistic regression analysis model was used to analyze related factors of atrial fibrillation.ResultsFinally, 11,524 hypertensive patients were enrolled, aged (64.1 +/- 9.8) years old, of which 5,542 were male. There were 388 patients with atrial fibrillation, aged (69.4 +/- 9.6) years old, of which 180 were males. The prevalence of atrial fibrillation among hypertensive populations in Wuyuan district, Jiangxi Province was 3.37%, of which 3.00% were males and 3.75% were females. The prevalence of atrial fibrillation among hypertensive patients < 45 years old is 1.70%, the prevalence rate of 45-65 years old is 1.89%, the prevalence rate of 65-75 years old is 4.18%, and the prevalence rate of >= 75 years old is 7.60%. The rate showed an upward trend with age (trend ?(2) = 112.83, P < 0.001). The results of multivariate regression analysis showed that age, gender, length of sleep, low-density lipoprotein, blood pressure, and total bilirubin were independent risk factors for atrial fibrillation.ConclusionsAge, gender, length of sleep, low-density lipoprotein, blood pressure level, and total bilirubin are related factors for the prevalence of atrial fibrillation in people with hypertension. Regular biochemical indicator monitoring should be conducted for key populations at high risk of atrial fibrillation. And actively carry out health education and intervention for high-risk groups of atrial fibrillation.
What problem does this paper attempt to address?